265 related articles for article (PubMed ID: 32387703)
21. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Otagiri M
J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
[TBL] [Abstract][Full Text] [Related]
23. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
Brayden DJ; Stuettgen V
Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
[TBL] [Abstract][Full Text] [Related]
24. Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells.
Krug SM; Amasheh M; Dittmann I; Christoffel I; Fromm M; Amasheh S
Biomaterials; 2013 Jan; 34(1):275-82. PubMed ID: 23069717
[TBL] [Abstract][Full Text] [Related]
25. The Ussing type chamber model to study the intestinal transport and modulation of specific tight-junction genes using a colonic cell line.
Bergmann H; Rogoll D; Scheppach W; Melcher R; Richling E
Mol Nutr Food Res; 2009 Oct; 53(10):1211-25. PubMed ID: 19764065
[TBL] [Abstract][Full Text] [Related]
26. Regulation of tight junction permeability by sodium caprate in human keratinocytes and reconstructed epidermis.
Kurasawa M; Kuroda S; Kida N; Murata M; Oba A; Yamamoto T; Sasaki H
Biochem Biophys Res Commun; 2009 Apr; 381(2):171-5. PubMed ID: 19338770
[TBL] [Abstract][Full Text] [Related]
27. Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber.
Majima A; Handa O; Naito Y; Suyama Y; Onozawa Y; Higashimura Y; Mizushima K; Morita M; Uehara Y; Horie H; Iida T; Fukui A; Dohi O; Okayama T; Yoshida N; Kamada K; Katada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Yasukawa Z; Tokunaga M; Okubo T; Itoh Y
J Dig Dis; 2017 Mar; 18(3):151-159. PubMed ID: 28139083
[TBL] [Abstract][Full Text] [Related]
28. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
29. Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers.
Watson CJ; Rowland M; Warhurst G
Am J Physiol Cell Physiol; 2001 Aug; 281(2):C388-97. PubMed ID: 11443038
[TBL] [Abstract][Full Text] [Related]
30. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology.
Chao AC; Nguyen JV; Broughall M; Griffin A; Fix JA; Daddona PE
Int J Pharm; 1999 Nov; 191(1):15-24. PubMed ID: 10556736
[TBL] [Abstract][Full Text] [Related]
32. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
Hossain S; Joyce P; Parrow A; Jõemetsa S; Höök F; Larsson P; Bergström CAS
Mol Pharm; 2020 Nov; 17(11):4226-4240. PubMed ID: 32960068
[TBL] [Abstract][Full Text] [Related]
33. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
34. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
35. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
36.
Tran H; Aihara E; Mohammed FA; Qu H; Riley A; Su Y; Lai X; Huang S; Aburub A; Chen JJH; Vitale OH; Lao Y; Estwick S; Qi Z; ElSayed MEH
Mol Pharm; 2023 Feb; 20(2):929-941. PubMed ID: 36592951
[TBL] [Abstract][Full Text] [Related]
37. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route.
Anderberg EK; Lindmark T; Artursson P
Pharm Res; 1993 Jun; 10(6):857-64. PubMed ID: 8321854
[TBL] [Abstract][Full Text] [Related]
38. Sodium caprate transiently opens claudin-5-containing barriers at tight junctions of epithelial and endothelial cells.
Del Vecchio G; Tscheik C; Tenz K; Helms HC; Winkler L; Blasig R; Blasig IE
Mol Pharm; 2012 Sep; 9(9):2523-33. PubMed ID: 22827574
[TBL] [Abstract][Full Text] [Related]
39. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
40. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
Kneiszl R; Hossain S; Larsson P
Mol Pharm; 2022 Jan; 19(1):124-137. PubMed ID: 34913341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
